News Image

Top movers in Monday's session

By Mill Chart

Last update: Mar 25, 2024

Monday's session: top gainers and losers

Top gainers

TickerChangeComment
INTZ1.0K%INTRUSION INC's (NASDAQ:INTZ) stock price displayed strong growth, advancing 1.0K% and reaching $3.57 during Monday's session. In the last month the stock gained 25.08%.
EGOX54.96%With a 54.96% surge, NEXT.E.GO NV's (NASDAQ:EGOX) stock price reached $0.06 during Monday's session, signaling positive momentum. In the last month the stock lost 68.81%.
MNY50.0%With a 50.0% surge, MONEYHERO LTD-A's (NASDAQ:MNY) stock price reached $2.06 during Monday's session, signaling positive momentum. Shareholders saw the stock price going 44.31% lower in the past month.
KULR40.95%With a 40.95% surge, KULR TECHNOLOGY GROUP INC's (NYSEARCA:KULR) stock price reached $0.3 during Monday's session, signaling positive momentum. Shareholders saw the stock price going 57.02% higher in the past month.
IDN30.39%INTELLICHECK INC's (NASDAQ:IDN) stock price is advancing with 30.39% to a price of $3.99. In the last month the stock gained 72.88%.
CYTO29.49%Investors witnessed a remarkable 29.49% rise in ALTAMIRA THERAPEUTICS LTD's (NASDAQ:CYTO) shares, which climbed to $2.24 during Monday's session. A press release (Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines) was released earlier today.
NKTX26.12%NKARTA INC's (NASDAQ:NKTX) shares rose 26.12% to $11.25. Earlier today the company had a press release: Nkarta Announces Pricing of $240 Million Underwritten Offering.
HYZN25.81%HYZON MOTORS INC (NASDAQ:HYZN) witnessed a notable 25.81% uptick in its shares, reaching $0.84 during Monday's session. Shareholders saw the stock price going 21.18% lower in the past 3 months.
XTLB25.19%Positive market sentiment drove XTL BIOPHARMACEUTICALS-ADR's (NASDAQ:XTLB) stock price up by 25.19% to $3.28 during Monday's session. In the last month the stock gained 216.0%.
MAIA25.12%Exciting news for MAIA BIOTECHNOLOGY INC (NYSEARCA:MAIA) as its stock price surged 25.12% to $2.64 during Monday's session. Shareholders saw the stock price going 52.9% higher in the past month.

For the full top gainers list go to our top gainers page.

Top losers

TickerChangeComment
MEDS-49.11%There was a notable decline in TRXADE HEALTH INC's (NASDAQ:MEDS) shares, as they dropped 49.11% to $12.25 during Monday's session. The company's earnings where released Yesterday. In the last month the share price increased with 193.0%.
SINT-47.68%SINTX TECHNOLOGIES INC's (NASDAQ:SINT) stock price faced a 47.68% decline, reaching $0.05 during Monday's session. In the last month the stock lost 34.49%.
AKAN-34.58%AKANDA CORP's (NASDAQ:AKAN) stock price is declining with 34.58% to a price of $0.16. Shareholders saw the stock price going 43.33% lower in the past 3 months.
CXAIW-31.25%KINS TECH GROUP CL A -CW25's (NASDAQ:CXAIW) shares fell 31.25% to $0.14. Shareholders saw the stock price going 104.0% higher in the past month.
FSR-28.13%FISKER INC's (NYSE:FSR) shares fell 28.13% to $0.09 during Monday's session. In the last month the stock lost 78.85%.
AEHR-26.82%AEHR TEST SYSTEMS's (NASDAQ:AEHR) stock price faced a 26.82% decline, reaching $10.73 during Monday's session. The stock is trading 48.01% lower than 3 months ago.
VMEO-25.6%There was a downturn in VIMEO INC's (NASDAQ:VMEO) shares, as they experienced a 25.6% decline, closing at $4.04 during Monday's session. Shareholders saw the stock price going 36.78% higher in the past month.
IVVD-23.28%INVIVYD INC's (NASDAQ:IVVD) stock price decreased by 23.28% to $3.35. Today NASDAQ:IVVD is releasing earnings. Shareholders saw the stock price going 167.0% higher is the past 6 months.
RBT-22.36%There was a downturn in RUBICON TECHNOLOGIES INC's (NYSE:RBT) shares, as they experienced a 22.36% decline, closing at $0.4 during Monday's session. Earlier today the company had a press release: Rubicon Launches Technical Advisory Services (TAS) Offering.
CGC-21.46%Investors witnessed a 21.46% decrease in CANOPY GROWTH CORP's (NASDAQ:CGC) stock price, which closed at $6.04 during Monday's session. In the last month the share price increased with 129.0%.

Our top losers page will show you the full list.

Back

INVIVYD INC

NASDAQ:IVVD (4/26/2024, 4:20:02 PM)

After market: 2.25 +0.1 (+4.65%)

2.15

+0.08 (+3.86%)

IVVD News

News Image14 days ago - InvivydInvivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
News Image14 days ago - InvivydInvivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

Invivyd Receives HCPCS Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) covering PEMGARDA...

News Image17 days ago - InvivydInvivyd Announces CEO Transition

Jeremy Gowler appointed Interim CEO

News Image17 days ago - InvivydInvivyd Announces CEO Transition

Jeremy Gowler appointed Interim CEO...

News Image24 days ago - InvivydInvivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
News Image24 days ago - InvivydInvivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million

PEMGARDA now commercially available in the U.S. for pre-exposure prophylaxis (PrEP) of COVID-19 in certain adults and adolescents with moderate-to-severe...

News Imagea month ago - BusinessInsiderIVVD Stock Earnings: Invivyd Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Invivyd (NASDAQ:IVVD) just reported results for the fourth quarter of 2023.Invi...

News Imagea month ago - InvestorPlaceIVVD Stock Earnings: Invivyd Misses EPS for Q4 2023

IVVD stock results show that Invivyd missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - InvivydInvivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
News Imagea month ago - InvivydInvivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

Received emergency use authorization for PEMGARDA™, a monoclonal antibody (mAb) authorized in the U.S. for pre-exposure prophylaxis (PrEP) of COVID-19 in...

IVVD Links
Follow us for more